SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2019 / Cilt: 47 - Sayı: 3

Cardiovascular effects of laparoscopic sleeve gastrectomy

Dimitri P. Mikhailidis
Niki KATSIKI
Pages
159–161
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thebody weight, BMI, and body surface area (BSA)were significantly reduced following the procedure:26.6±10.9 kg, 8.8±3.9 kg/m2, and 0.27±0.12 m2, respectively(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this issue of the Archives of The Turkish Societyof Cardiology, Simsek et al.[1] have evaluated theshort-term (3 months) effects of laparoscopic sleevegastrectomy (LSG) on body weight and echocardiographicdiastolic function.
📊
Key Findings & Data:Briefly, 41 obese patients[mean age: 42.8 years; 51.1% female; mean bodymass index (BMI): 44.9 kg/m2] underwent LSG.
💡
Conclusion & Impact:Thebody weight, BMI, and body surface area (BSA)were significantly reduced following the procedure:26.6±10.9 kg, 8.8±3.9 kg/m2, and 0.27±0.12 m2, respectively(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this issue of the Archives of The Turkish Societyof Cardiology, Simsek et al.[1] have evaluated theshort-term (3 months) effects of laparoscopic sleevegastrectomy (LSG) on body weight and echocardiographicdiastolic function. Briefly, 41 obese patients[mean age: 42.8 years; 51.1% female; mean bodymass index (BMI): 44.9 kg/m2] underwent LSG. Thebody weight, BMI, and body surface area (BSA)were significantly reduced following the procedure:26.6±10.9 kg, 8.8±3.9 kg/m2, and 0.27±0.12 m2, respectively(p

🔖

Cite This Article

Mikhailidis, D. P., KATSIKI, N. (2022). Cardiovascular effects of laparoscopic sleeve gastrectomy. Türk Kardiyoloji Derneği Arşivi, Cilt: 47 - Sayı: 3, 159–161. https://ajindex.com/articles/632077

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Simsek MA, Cabbar AT, Ozveren O, Aydin S, Tascilar O, Degertekin M. Short-term effects of sleeve gastrectomy on weight loss and diastolic function in obese patients. Turk Kardiyol Dern Ars 2019;47:162–7
  2. Katsiki N, Mikhailidis DP, Papanas N. Left atrial volume: An independent predictor of cardiovascular outcomes. Int J Cardiol 2018;265:234–5
  3. Iancu ME, Copăescu C, Şerban M, Ginghină C. Favorable changes in arterial elasticity, left ventricular mass, and diastolic function after significant weight loss following laparoscopic sleeve gastrectomy in obese individuals. Obes Surg. 2014;24:364–70
  4. Leung M, Xie M, Durmush E, Leung DY, Wong VW. Weight Loss with Sleeve Gastrectomy in Obese Type 2 Diabetes Mellitus: Impact on Cardiac Function. Obes Surg 2016;26:321–6
  5. Kemaloğlu Öz T, Ünal Dayı Ş, Seyit H, Öz A, Ösken A, Atasoy I, et al. The effects of weight loss after sleeve gastrectomy on left ventricular systolic function in men versus women. J Clin Ultrasound 2016;44:492–9
  6. Ricci MA, Ministrini S, De Vuono S, Camilli M, Gentili A, Daviddi G, et al. Sleeve gastrectomy efficacy on metabolic and cardiovascular dysfunction with a focus on the role of comorbidities. Angiology 2018;69:475–82
  7. Cavarretta E, Casella G, Calì B, Dammaro C, Biondi-Zoccai G, Iossa A, et al. Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy. World J Surg 2013;37:565– 72
  8. Aminian A, Brethauer SA, Andalib A, Punchai S, Mackey J, Rodriguez J, et al. Can Sleeve Gastrectomy “Cure” Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes. Ann Surg 2016;264:674–81
  9. Tromba L, Tartaglia F, Carbotta S, Sforza N, Pelle F, Colagiovanni V, et al. The Role of Sleeve Gastrectomy in Reducing Cardiovascular Risk. Obes Surg 2017;27:1145–51
  10. Katsiki N, Athyros VG, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Should we expand the concept of coronary heart disease equivalents? Curr Opin Cardiol 2014;29:389– 95
  11. Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? Curr Vasc Pharmacol 2018;16:219–27
  12. Koh ZJ, Salgaonkar HP, Lee WJJ, Kim GW, Tan CH, Cheng A, et al. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort. Obes Surg 2019;29:862–8
  13. Berry MA, Urrutia L, Lamoza P,